EMFAT
RXDX

Emerald Mutual Fund Advisers Trust’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-104,825
Closed -$11.2M 285
2023
Q1
$11.2M Sell
104,825
-15,920
-13% -$1.71M 0.66% 69
2022
Q4
$13.3M Buy
+120,745
New +$13.3M 0.82% 55